SEPTEMBER 2023LIFE SCIENCES REVIEW1LIFESCIENCESREVIEW.COMSEPTEMBER - 25 - 2023 ISSN 2831-8331CANCERIMMUNOTHERAPYTHE CANCER IMMUNOTHERAPY TREATMENT PARADIGMCharles G. Drake,M.D., Ph.D., Vice President,Immuno-Oncology, The Janssen Pharmaceutical Companies of Johnson & JohnsonE DI T IO N
Page 2 >